2025 Speakers

The event has now run!

Antony Mattesich, Chief Executive Officer, Amphista

Antony Mattesich

Chief Executive Officer

Amphista

Dan Elbaum, Chief Scientific Officer, QurAlis

Dan Elbaum

Chief Scientific Officer

QurAlis

David Donabedian, Executive Partner, Longwood Fund

David Donabedian

Executive Partner

Longwood Fund

Eliseo Salinas, Head of Research & Development, Delix Therapeutics

Eliseo Salinas

Head of Research & Development

Delix

Jenny Laird, Vice President, Search & Evaluation Neuroscience, Eli Lilly

Jenny Laird

Vice President, Search & Evaluation Neuroscience

Eli Lilly

John Mayfield, Senior Vice President, Business Development & Strategy, Flagship Pioneering

John Mayfield

Senior Vice President, Business Development & Strategy

Flagship Pioneering

Vidya Nadar, Director, Search & Evaluation, Rare & Neurological Disorders, Sanofi (2)

Jonathan Levenson

Chief Scientific Officer

FireCyte Therapeutics

Laxminarayan Bhat, Founder, President & Chief Executive Officer, Reviva Pharma

Laxminarayan Bhat

Founder, President & Chief Executive Officer

Reviva Pharma

Maria Maccecchini, Founder, President & CEO, Annovis

Maria Maccecchini

Founder, President & CEO

Annovis

Mathias Schmidt, CEO, ArmaGen; Executive Fellow, JCR Pharmaceuticals

Mathias Schmidt

CEO | Executive Fellow

ArmaGen | JCR Pharmaceuticals

Michaela Tolman, Director, Commercial Planning, Pfizer

Michaela Tolman

Senior Director, Pipeline Strategic Planning

Pfizer

Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, Corporate Strategy, AbbVie

Murali Gopalakrishnan

Global Head, Neuroscience Search & Evaluation, Corporate Strategy

AbbVie 

Sam Alworth, Co-Founder & Chief Executive Officer, AcuraStem

Sam Alworth

Co-Founder & Chief Executive Officer

AcuraStem

Shaheen Lakhan, Chief Medical Officer, Click Therapeutics

Shaheen Lakhan

Chief Medical Officer

Click Therapeutics

Stacie Weninger, President, F-Prime Capital

Stacie Weninger

President

FBRI

Vidya Nadar, Director, Search & Evaluation, Rare & Neurological Disorders, Sanofi

Vidya Nadar

Director, Search & Evaluation, Rare & Neurological Disorders

Sanofi

Vidya Nadar, Director, Search & Evaluation, Rare & Neurological Disorders, Sanofi

Neel Desai

Executive Director, Business Development

Biogen 

Michaela Tolman, Director, Commercial Planning, Pfizer

Alan Fu

CFO

IASO Biotechnology

Michaela Tolman, Director, Commercial Planning, Pfizer (2)

Irena Melnikova

Partner

Pfizer Ventures

Michaela Tolman, Director, Commercial Planning, Pfizer (1)

Catherine Abbadie

External Innovation Lead

Biogen

Michaela Tolman, Director, Commercial Planning, Pfizer (3)

Sam Banister

Co-founder & Chief Scientific Officer

Xylo Bio

Michaela Tolman, Director, Commercial Planning, Pfizer (4)

Doug Drysdale

Chief Executive Officer

Cybin

Michaela Tolman, Director, Commercial Planning, Pfizer (5)

Hong Chen

Director, Search & Evaluation

Novo Nordisk

Michaela Tolman, Director, Commercial Planning, Pfizer (6)

Raymond Houck

Chief Executive Officer

Aclipse Therapeutics

Michaela Tolman, Director, Commercial Planning, Pfizer (8)

Rakhee Ganti

Founder & Chief Executive Officer

Dimer Pharmaceuticals

Michaela Tolman, Director, Commercial Planning, Pfizer (9)

Navin Swaroop

Executive Director, Business Development

EMD Serono

Michaela Tolman, Director, Commercial Planning, Pfizer (7)

Marcel van der Brug

Chief Scientific Officer

AcuraStem

2025 FULL EVENT GUIDE
REGISTER INTEREST
To the top